News

This study demonstrates that the protocol-specified, intent-to-treat, primary endpoint comparison of a six-month course of rifaximin at 550mg dosed twice-a-day provides a highly statistically significant result in preventing

The data showed that Cimzia (certolizumab pegol) – the only PEGylated anti-TNF alpha (tumor necrosis factor alpha) – significantly improved endoscopic lesions and induced endoscopic response (as assessed

Mr Slattery is currently on the boards of Micromet, a biopharmaceutical company, and TranS1, a medical device company. Mr Slattery also served as senior vice president and CFO

According to the company, Rapid 5 Access brings many advantages to the capsule endoscopy program: it utilizes existing computers and network system to create, manage and store PillCam

Mr Cooper, who was serving as interim chairman, will be stepping down from the board to focus on his activities as a director at Grant Samuel. Mr Drona

In its summary judgment ruling, the court found that the administration of Enbrel falls outside the scope of the asserted claims based on the court’s interpretation of these

Durezol, which was approved by the FDA in June 2008, is a topical ophthalmic corticosteroid indicated for the treatment of inflammation and pain associated with ocular surgery. Susan

Ovation acquired the exclusive US license to ATryn from GTC Biotherapeutics, allowing the company to develop and commercialize the product in the US. The acceptance of the biologics

Biocept also appointed Edward Dennis as a director. The company announced the resignation of its former CEO, president and director, Gordon Janko. Dr Coutts has 30 years of